Prelude Capital Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Prelude Capital Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-219,643	Closed	-$3.71M	–	1496
2023 Q2	$3.71M	Buy	+219,643	New	+$2.89M	0.24%	79

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Prelude Capital Management's VECT Position: Q3 2023 in Review

Prelude Capital Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 219,643 shares — an estimated $3.71M sold.

Prelude Capital Management first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $3.71M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Prelude Capital Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Prelude Capital Management sold 219,643 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $3.71M.
Prelude Capital Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
Prelude Capital Management's VectivBio Holding AG Ordinary Shares position peaked at $3.71M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.